ArticleFrontiers in oncology2025
Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis.Radiology and oncology · 2026Article
- Habitat analysis and other AI technologies for Ki-67 prediction in hepatocellular carcinoma: a multi-center study.BMC cancer · 2026Article
- Ki-67 expression correlates with hepatocellular carcinoma recurrence and is predictable using radiomics features.Abdominal radiology (New York) · 2026Article
- Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers.Journal of hepatocellular carcinoma · 2026Article
- The performance of DWI and ADC values with different b-values for the diagnosis and staging of endometrial carcinoma at 3T.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore whether a combination of clinico-radiological factors and histogram parameters based on monoexponential, biexponential, and stretched exponential models derived from the whole-tumor volume on diffusion-weighted imaging (DWI) could predict Ki-67 expression in hepatocellular carcinoma(HCC). Materials and Methods: Histogram parameters based on whole-tumor volumes were derived from monoexponential model, biexponential model, and stretched exponential model. Histogram parameters were compared between HCCs with high and low Ki-67 expression. Multivariate logistic regression and receiver operating characteristic curves were used to assess the ability to predict Ki-67 expression (expression index ≤ 20% vs. >20%). Results: In the training and test set, the 5th percentile of distributed diffusion coefficient (DDC) yielded the area under the curve (AUC) value of 0.816 (95% CI 0.713 to 0.894) and 0.867 (95% CI 0.655 to 0.972), respectively. Multivariable analysis showed that alpha-fetoprotein (AFP) level, skewness of perfusion fraction(f), and 5th percentile of DDC were independent predictors of high Ki-67 expression in HCCs. In the training and test sets, the AUC of the combined model for predicting high Ki-67 expression in HCCs were 0.902 (95% CI 0.814 to 0.957) and 0.908 (95% CI 0.707 to 0.989), respectively. Conclusion: Histogram parameters of multiple mathematical DWI models can be useful for predicting high Ki-67 expression in HCCs, and our combined model based on AFP level, skewness of f, and 5th percentile of DDC may be an effective approach for predicting Ki-67 expression in HCCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.